This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Tobacco Cessation
and you are
between 18 and 60
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Data suggest that progesterone may improve smoking cessation outcomes perhaps by reducing impulsive behavior. However, the clinical literature on this topic is lacking. Therefore, in Project I we are proposing a double-blind randomized controlled trial to assess the role of exogenous progesterone on impulsivity and smoking cessation in a sample of males and females who are motivated to quit smoking.

Provided treatments

  • Other: Placebo
  • Drug: Progesterone
  • Other: Smoking Cessation Behavioral Counseling

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01744574. The sponsor of the trial is University of Minnesota - Clinical and Translational Science Institute and it is looking for 216 volunteers for the current phase.
Official trial title:
Sex Differences & Progesterone: Association With Impulsivity and Smoking Cessation